| 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2-Acetylaminofluorene | 
CAS 53-96-3 | ||
C15H13NO | 
RTECS AB9450000 | ||
| 
Synonyms & Trade Names  AAF, 2-AAF, 2-Acetaminofluorene, N-Acetyl-2-aminofluorene, FAA, 2-FAA, 2-Fluorenylacetamide  | 
DOT ID & Guide  | 
||
Exposure
 | 
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL: [1910.1014] See Appendix B | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
| 
Physical Description  Tan, crystalline powder.  | 
|||
| 
MW: 223.3 | 
BP: ? | 
MLT: 381°F | 
Sol: Insoluble | 
| 
VP: ? | 
IP:? | 
 | 
Sp.Gr: ? | 
| 
Fl.P: ? | 
UEL: ? | 
LEL: ? | 
 | 
| Combustible Solid | |||
| 
Incompatibilities & Reactivities  None reported  | 
|||
| 
Measurement Methods  None available See: NMAM or OSHA Methods  | 
| 
Personal Protection & Sanitation (See protection)  Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench  | 
First Aid (See procedures)  Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately  | 
| 
Important additional information about respirator selection Respirator Recommendations (See Appendix E) NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus  | 
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Reduced function of liver, kidneys, bladder, pancreas; [potential occupational carcinogen] | |
| 
Target Organs 
Liver, bladder, kidneys, pancreas, skin  Cancer Site [in animals: tumors of the liver, bladder, lungs, skin & pancreas]  | 
|
| See also: INTRODUCTION See MEDICAL TESTS: 0004 |